RebiQoL : A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif

MLA

Landtblom, Anne-Marie, et al. RebiQoL : A Randomized Trial of Telemedicine Patient Support Program for Health-Related Quality of Life and Adherence in People with MS Treated with Rebif. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....e92e2e2e8641519c449a658fe58b372f&authtype=sso&custid=ns315887.

APA

Landtblom, A.-M., Guala, D., Martin, C., Olsson-Hau, S., Haghighi, S., Jansson, L., & Fredrikson, S. (2019). RebiQoL : A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif.

Chicago

Landtblom, Anne-Marie, Dimitri Guala, Claes Martin, Stefan Olsson-Hau, Sara Haghighi, Lillemor Jansson, and Sten Fredrikson. 2019. “RebiQoL : A Randomized Trial of Telemedicine Patient Support Program for Health-Related Quality of Life and Adherence in People with MS Treated with Rebif,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....e92e2e2e8641519c449a658fe58b372f&authtype=sso&custid=ns315887.